540222:BOM
Laurus Labs Ltd
2Â 059,00Â INR
arrow_upward
+1,93%(+39,00) 1 d
16 okt., 15:59:49 GMT+5:30 · INR
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för 540222 …
Öppen
2Â 027,35Â INR
Högt
2Â 086,00Â INR
LÃ¥gt
2Â 027,35Â INR
Börsvärde
1,11Â bn
Genomsn. vol.
84,29Â tn
Volym
103,13Â tn
Utdelning
0,10Â %
Kvartalsvis utdelning
0,50Â INR
Ex-utdelningsdatum
8 maj 2026
P/E-tal
101,80
52v högst
2Â 086,00Â INR
52v lägst
870,05Â INR
EPS
20,23Â INR
Utestående aktier
106,44Â mn
Antal anställda
7Â tn
Öppen
2Â 027,35Â INR
Högt
2Â 086,00Â INR
LÃ¥gt
2Â 027,35Â INR
Börsvärde
1,11Â bn
Genomsn. vol.
84,29Â tn
Volym
103,13Â tn
Utdelning
0,10Â %
Kvartalsvis utdelning
0,50Â INR
Ex-utdelningsdatum
8 maj 2026
P/E-tal
101,80
52v högst
2Â 086,00Â INR
52v lägst
870,05Â INR
EPS
20,23Â INR
Utestående aktier
106,44Â mn
Antal anställda
7Â tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
The Economic Times
·
för 2 dagar sedan
Laurus Labs shifts gears as CDMO emerges as key growth driver; Nuvama sees 24% upside
Profil
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Om Laurus Labs Ltd